BioSpace News Archive

Vizgen has announced that Bob Koshgarian has joined the leadership team as Vice President of Operations. I

Inhibikase Therapeutics, Inc. today announced that, after a review of safety, tolerability and pharmacokinetic data from the Company’s Phase 1 clinical trial of IkT-148009 in healthy volunteers, the United States Food and Drug Administration (FDA) has given the Company clearance to begin a Phase 1b extension study to evaluate its lead drug candidate IkT-148009 in Parkinson’s patients.

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the appointment of Myriam J. Curet, M.D., to its Board of Directors.

Generex Biotechnology Corporation announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc.

Synaptogenix, Inc. today announced that its abstract for presentation at the Alzheimer’s Association International Conference (AAIC) is now available entitled “Bryostatin Restores Cognitive Functions Above Baseline in Advanced Alzheimer’s Disease (AD) Patients: A Regenerative Therapeutic Strategy.”

Cumberland Pharmaceuticals Inc. today released its 2020 Sustainability Report, which details the company’s activities pertaining to environmental, social and governance (ESG) matters.

One of the integral part of ophthalmic division is ophthalmic imaging. It permits the clinician to keep an observation on the findings through clinical ocular examination in an objective, transmissible, reproducible, and durable manner.

BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the launch of its Malaria project, which aims to develop a well-tolerated and highly effective Malaria vaccine and implement sustainable vaccine supply solutions on the African continent.